A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium.

Sweeney, C J

A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium. [electronic resource] - Cancer Aug 1999 - 514-8 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

0008-543X

10.1002/(sici)1097-0142(19990801)86:3<514::aid-cncr21>3.0.co;2-9 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carcinoma, Transitional Cell--drug therapy
Drug Administration Schedule
Drug Evaluation
Female
Humans
Ifosfamide--administration & dosage
Male
Middle Aged
Paclitaxel--administration & dosage
Survival Analysis
Urologic Neoplasms--drug therapy
Urothelium